NEUROwave - Extracorporeal Shock Wave Therapy (ESWT) in Acute Traumatic Complete (AIS A) and Incomplete (AIS B-D) Cross-sectional Lesions on Motor and Sensory Function Within Six Months After Injury

About this trial

This trial is recruiting individuals with acute spinal cord injuries to test the effect of non-invasive low energy extracorporeal shockwave therapy (ESWT) on recovery. ESWT uses an acoustic shockwave which carries energy to the bones, tendons and other soft tissue. It is commonly used to treat kidney stones and in physical therapy. Researchers believe the therapy can preserve nerves that are vulnerable to secondary effects of SCI, e.g. inflammation, scarring, edema. Trial participants will receive either 1) ESWT; or 2) sham-ESWT within 48 hours of spinal cord injury. The device will be applied 5 segments above and below the injury level of the spinal cord and to the soles of the feet. Final testing will be performed after 6 months. This is a one-time treatment. Changes in motor or sensory function will be measured for up to 6 months.